Previous Close | 0.6100 |
Open | 0.6100 |
Bid | 0.0000 |
Ask | 0.7000 |
Strike | 2.00 |
Expire Date | 2024-12-20 |
Day's Range | 0.6100 - 0.6100 |
Contract Range | N/A |
Volume | |
Open Interest | 108 |
PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, in collaboration with the international Consortium for Long-Read Sequencing (CoLoRS), today announced the launch of the first publicly available and free HiFi long-read variant frequency database with global representation. This innovative resource fills a critical void for rare disease researchers, providing access to genetic variants that are not detectable through short-read sequencing methods. B
PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.
Why does Cathie Wood think investors' fear about stocks is at "Great Depression" levels? Because it is for her portfolio.